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Introduction
Macrolides antibiotics, such as clarithromycine express
immunomodulatory and tissue reparative effects that are
distinct from their anti-infective properties, and have in
vitro efficacy against neutrophils.
Aim of study
To determine the efficacy of add-on therapies that target
eosinophilic and noneosinophilic airway inflammation
and their effects on asthma control test, pulmonary
function and asthma symptoms.
Methods
single blind randomized clinical trial; asthmatic children
with persistent symptoms undergoing treatment with
fluticasone 100 mg bid and b2 agonist as required
were studied. Group A (23 males / 17 females, aged
11.5±1.8 years) received fluticasone 200mg bid, and
group B (21 males / 19 females, aged 11.5±1.8 years)
clarithromycine 15 mg/kg bid, in addition to fluticasone
100 mg bid for 8 weeks. (FEV1%, C-CAT, SABA use,
sputum induced % of eosinophils and neutrophils) were
compared before and after treatment in each group.
Results
In group A there is significant reduction of eosinophils
percentage after treatment, and non significant increase
in neutrophils percentage. There was significant
improvement in FEV1% predicted. While in group B
there was non significant decrease in eosinophils, and
significant decrease in neutrophils. In group A there was
significant negative correlation between changes in
FEV1% and change in eosinophils and week positive
correlation between changes in FEV1% and changes in
neutrophils. In group B there was significant positive
correlation between basal eosinophils and change in
FEV1% and significant negative correlation between
basal neutrophils and change in FEV1%.
Conclusion
Steroids were effective in targeting eosinophilic inflamma-
tion and clarithromycine target neutrophilic inflammation.
High eosinophils and neutrophils percentage in sputum
are best predictors of response to steroids or clarithromy-
cine treatment respectively.
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